|
English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 18076/20274 (89%)
造訪人次 : 5356205
線上人數 : 1139
|
|
|
資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/32536
|
標題: | Gamma knife radiosurgery for the treatment of cavernous sinus meningiomas: post-treatment long-term clinical outcomes, complications, and volume changes |
作者: | Yi-Chieh Hung(洪翊傑) Lee, Cheng-Chia Guo, Wan-Yuo Shiau, Cheng-Ying Chang, Yue-Cune Pan, David Hung-Chi Sheehan, Jason P. Chung, Wen-Yuh |
貢獻者: | Chi Mei Med Ctr, Dept Neurosurg Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm Univ Virginia Hlth Syst, Dept Neurosurg Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg Natl Yang Ming Univ, Sch Med Taipei Vet Gen Hosp, Dept Radiol Taipei Vet Gen Hosp, Canc Ctr Tamkang Univ, Dept Math Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg |
關鍵字: | Cavernous sinus Meningioma Prognostic factor Radiosurgery |
日期: | 2019-06 |
上傳時間: | 2020-07-29 13:48:55 (UTC+8) |
出版者: | SPRINGER |
摘要: | PurposeTo evaluate the outcomes of patients who underwent Gamma Knife radiosurgery (GKRS) for the treatment of cavernous sinus (CS) meningiomas.MethodsWe retrospectively reviewed the clinical and radiological outcomes of 95 patients with CS meningiomas at Taipei Veterans General Hospital between 1993 and 2011. The study cohort comprised 27 men and 68 women with a median age of 50years (range 29-79years). The median pre-GKRS tumor volume was 6.6ml (range 0.9-35.7ml). The median margin dose was 12Gy (range 11-21Gy). The clinical factors related to favorable outcomes were assessed.ResultsThe median follow-up period was 59 (range 12-209) months. At the final follow-up, the tumor volume regressed in 70 patients (74%) and progressed in eight (8%). Kaplan-Meier analysis revealed that the progression-free survival rates at 5 and 10years were 92.7% and 81.2%, respectively. Three patients (3.2%) experienced exacerbated cranial nerve dysfunction following radiosurgery. Confined tumors were found to be an independent prognostic factor for tumor control and shorter times to regression in the multivariable analyses. No risk factor for tumor progression was identified in either the univariate or multivariate analyses.ConclusionsGKRS provides good long-term tumor control and is associated with low cranial nerve-related morbidity development rates in patients with small- to medium-sized CS meningiomas. Confined tumor could be an independent prognostic factor for tumor control and shorter times to regression in multivariate analysis. Life-long follow-up is mandatory in such settings, even for outpatients with shrunken or stabilized tumors. |
關聯: | Journal of Neuro-Oncology, v.143, n.2, pp.261-270 |
顯示於類別: | [醫務管理系(所)] 期刊論文
|
文件中的檔案:
檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
index.html | | 0Kb | HTML | 1322 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|